Masterclass: DTx Reimbursement in the US - Value-Based Contracting Basics

Establishing reimbursement and achieving payment not less than real value by payers is key to achieving higher revenues for DTx products. Attracting the interest of payers and PBMs and compelling a reimbursement evaluation of a DTx product is the first big challenge. But once you establish meaningful engagement and initiate the coverage consideration dialogue, a next big step is defining and negotiating contract terms. In this masterclass led by biopharma and PDT outcomes-based contracting pioneer, Mike Pace, we will focus on value-based contracts and their application in US DTx market access and payer engagement strategy: